Joanna Fowler, Ph.D., a major contributor to brain research and a pioneer in molecular imaging, has been awarded the National Medal of Science, the nation’s highest award for lifetime achievement in science.
Joanna Fowler, Ph.D., a major contributor to brain research and a pioneer in molecular imaging, has been awarded the National Medal of Science, the nation’s highest award for lifetime achievement in science.
A senior researcher at the U.S. Department of Energy's Brookhaven National Laboratory in Upton, NY, Fowler was a member of the research team that in 1976 first synthesized fluorine-18 fluorodeoxyglucose (F-18 FDG), the workhorse radiotracer for PET/CT imaging. Her groundbreaking research on neurotransmitters using PET led to a better understanding of addiction and to insights into the cause and possible treatment of Parkinson’s disease.
Fowler and eight other researchers were presented medals at a White House ceremony Oct. 7.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.